ArticleDiscover oncology2026

miR-155-5p promotes osteosarcoma progression and cisplatin resistance by targeting the SOCS1/STAT1/c-Fos signaling axis.

Jian Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.